Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Short stature due to partial GHR deficiency is a rare, genetic, endocrine disease characterized by idiopathic short stature due to diminished GHR function (decreased ligand binding or reduced availability of receptor), thus resulting in partial insensitivity to growth hormone.
Features include very common findings: Short stature, Decreased serum insulin-like growth factor 1, Delayed skeletal maturation, and Growth delay; and sometimes findings: Delayed puberty, Hypoglycemia, and Midface retrusion.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 3 | Short stature, Decreased serum insulin-like growth factor 1, Growth delay |
GHR encodes growth hormone receptor (638 aa). Receptor for pituitary gland growth hormone (GH1) involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway Highest expression in Adipose Subcutaneous (51.4 TPM) and Adipose Visceral Omentum (41.4 TPM).
Short stature due to partial GHR deficiency is associated with mutations in the GHR gene on chromosome 5.
The GHR protein participates in GHR internalization pathway.
GHR is classified as a druggable target (Cell Surface, Druggable Genome, and External Side Of Plasma Membrane categories) with score 10.4.
Genetic testing for GHR is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 very common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for short stature due to partial GHR deficiency.
3 publications have been identified in PubMed for short stature due to partial GHR deficiency. Research spans Other (33%), Review / Meta-Analysis (33%), and Case Report / Case Series (33%).
Niehues T (2024). [PMID: 39381601](https://pubmed.ncbi.nlm.nih.gov/39381601/). *Allergol Select*. [Other]
Plachy L (2024). [PMID: 39749023](https://pubmed.ncbi.nlm.nih.gov/39749023/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Çelik NB (2024). [PMID: 36688726](https://pubmed.ncbi.nlm.nih.gov/36688726/). *J Clin Res Pediatr Endocrinol*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 6:22 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Hormones |
2 |
Decreased serum insulin-like growth factor 1, Delayed puberty |
Bones and joints | 1 | Delayed skeletal maturation |